Tc. Cesario et al., ENHANCED YIELDS OF GAMMA-INTERFERON IN PROLACTIN TREATED HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Proceedings of the Society for Experimental Biology and Medicine, 205(1), 1994, pp. 89-95
Prolactin is a peptide hormone with effects on a number of target orga
ns including the immune system. It has been shown that animals rendere
d hypoprolactinemic have impaired delayed hypersensitivity, impaired m
acrophage activation and altered secretion of gamma interferon (IFN).
Using peripheral blood mononuclear cells (PBMC) and inducing the cells
to produce gamma IFN with a range of inducers, we have studied the ef
fects of a number of hormones on IFN production. Using cells from norm
al donors, we have found that prolactin in concentrations of 10(-8) M
or greater, can significantly enhance the production of gamma IFN. The
effect was dose related and was observed when lectins (PHA and Con A)
, but not anti CD3 antibodies, ionophones, or IL-2 were used to induce
the cells. The presence of prolactin in concentrations above that enc
ountered in the fetal bovine serum used to incubate the cells resulted
in a doubling or more of the IFN produced. The tests were performed o
n 30 occasions with cells drawn from 21 individuals. On all but three
occasions, yield enhancement was observed in the presence of prolactin
. The mechanism of the effect was investigated, and genistein, a tyros
ine kinase inhibitor, was found to abort the Influence of prolactin on
gamma IFN production. These studies indicate prolactin in physiologic
al concentrations can enhance the production of gamma IFN from cells f
rom normal donors.